1978
DOI: 10.1001/archneur.1978.00500360062013
|View full text |Cite
|
Sign up to set email alerts
|

Neuroanatomical and Electroencephalographic Correlations in Sanfilippo Syndrome, Type A

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0
2

Year Published

1981
1981
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(8 citation statements)
references
References 10 publications
1
5
0
2
Order By: Relevance
“…The brain does not have any changes of group I, but the MRI showed diffusely increased intensity of the white matter (group II) and severe brain atrophy (group IV). Neurons might be directly damaged in the patients with MPS III 16, 19. Thus, the diffuse intensity change would mean neuronal loss, which was consistent with the decreased ratio of NAA/Cr by MRS analysis in patients 15 and 17.…”
Section: Discussionsupporting
confidence: 64%
“…The brain does not have any changes of group I, but the MRI showed diffusely increased intensity of the white matter (group II) and severe brain atrophy (group IV). Neurons might be directly damaged in the patients with MPS III 16, 19. Thus, the diffuse intensity change would mean neuronal loss, which was consistent with the decreased ratio of NAA/Cr by MRS analysis in patients 15 and 17.…”
Section: Discussionsupporting
confidence: 64%
“…Although little is known about early disease development, MPS III mainly affects the neurons of the central nervous system causing dementia, mental retardation, delayed development, and neurological dysfunction (157,238,239). Typical neuropathological lesions include loss or ballooning of purkinje cells and accumulation of molecular layer dendrites with storage material (157,(240)(241)(242). Death usually occurs in the patient's early twenties to early thirties, for patients with the severe form, while patients suffering from the attenuated form have longer survival times (243)(244)(245).…”
Section: Mucopolysaccharidosis In Humansmentioning
confidence: 99%
“…В работах зарубежных [14,15,17], а также российских авторов показано [6,16], что самая высокая доля больных с эпилепсией наблюдается при нейроно-патических типах МПС II и III. По данным международных и отечественных исследователей, среди больных МПС II распространенность эпилепсии колеблется в диапазоне от 13 до 34% [17][18][19], с более высоким процентом (от 28 до 63%) у больных с нейронопатическим феноти-пом [20][21][22]; средний возраст появления эпилептиче-ских приступов -~10 лет [16][17][18]. По данным I.…”
Section: распространенность эпилепсии при мукополисахаридозахunclassified
“…Пациенты с МПС III, характеризующегося пораже-нием центральной нервной системы [18], имеют самый высокий показатель распространенности эпилепсии -от 26 до 52% [20,21,23]. Распространенность несу-щественно отличается среди четырех подтипов МПС III, но более ранний дебют эпилепсии был установлен у боль-ных МПС IIIа [24].…”
Section: распространенность эпилепсии при мукополисахаридозахunclassified